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The finding of an acquired B antigen, together 
with plyagglutination, in an elderly man led to 
studies indicating adsorption of bacterial material 
as the likely cause of both of these red blood cell 
anomalies. The various causes of plyagglutination 
are durcussed. Based upon the differendal char- 
acteristia of each type, a classification of ply 
agglutination is proposed. 
POLYACCLUTINATION denotes the aggluti- 
nation of red blood cells by most normal 
adult sera, but not by the sera of newborn 
infants. This abnormality has been noted 
most frequently in association with either 
bacterial contamination in uitro or bac- 
terial infection in vivo. When observed in 
vivo, the phenomenon usually is temporary, 
although occasionally it has persisted for 
months25 or even for several years.14 
Red blood cells treated with neuramin- 
idase provide a model of polyagglutination. 
This enzyme splits N-acetyl-neuraminic 
acid from sialo-mucoproteins16 exposing 
structures capable of reacting with the anti- 
T agglutinin of normal serum, and this, or 
a very similar mechanism, probably is re- 
sponsible for most cases of T-activation 
in vivo. In addition, the polyagglutinable 
state in vivo occasionally results from 
causes other than classical T-activation, a 
condition termed “atypical” polyagglutina- 
This report describes a further case of 
atypical polyagglutination; however, in this 
instance it is associated with an acquired 
B antigen. 
tion.5, 9. 13. 14. 16 
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Materials and Methods 
Serum was obtained from clotted blood 
samples and stored frozen until tested. Red 
blood cell suspensions were prepared from 
whole blood or EDTA anticoagulated samples 
as two to five per cent suspensions in saline. 
T-activating enzyme, T-active red blood cells 
and anti-T lectin were prepared as previously 
described. 1 
Adsorption was performed by incubating 
equal volumes of packed cells and serum for 
one hour at 4 C. Group AB sera were auto- 
adsorbed overnight at 4 C. 
Eluates were prepared by the heat method of 
Landsteiner and Miller.17 
2-mercapto-ethanol (2-ME) denaturation was 
camed out by incubating equal volumes of 
serum and of 0.1M 2-ME at 37 C for two hours. 
The serum was cleared of 2-ME by dialysis 
against running water for 45 minutes followed 
by two changes of 500 ml volumes of physio- 
logic saline solution for 30 minutes each. 
Concentration of serum was accomplished 
with Carbowax.’ Two ml of serum were di- 
alysed against Carbowax until the volume had 
been reduced to 0.5 ml. 
Saliva specimens were placed in a boiling 
water bath for 10 minutes immediately after 
collection, centrifuged, and stored frozen. 
Neutralization tests were performed by ad- 
ding two volumes of serum or eluate to one 
volume of saliva. One volume of cells was 
added after a five-minute neutralization period. 
Secretor status was determined by adding an 
equal volume of diluted antiserum to saliva. 
One volume of appropriate test cells was added 
after a 30-minute neutralization period. Re- 
sults were read following incubation at room 
temperature for 30 minutes. 
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TABLE 1. Initial Reactions of Patient’s Blood 








Anti-T ( l d n )  
0 
Reactions of patient’s 
m u m :  
A, cells A, cells B cells 0 cells 0. T-active cells Patient’s cells 
0 0 3+ 0 2+ 0 
Case Report Serologic Studies 
A 94-year-old Caucasian man was admitted to The finding of a weak B antigen together 
the hospital in August 1970. with an acute urinary with  anti-^ in the Serum of a patient pre- tract infection. He also had prostatic hyperplasia 
and mild diabetes mellitus. An organism belonging Viously found to be type A suggested two 
to the Klebsiella-enterobacter POUP was isolated possibilities: an acquired B antigen or poly- 
from his urine. He was treated with catheter agglutinability of erythrocytes. Accord- 
drainage and antibiotics, and was scheduled for 
a transurethral resection of the orostate. ingly, the patient’s cells were tested with 
Preoperative blood typing results were anomalous. 
His cells reacted with anti-A and weakly with 
anti-B; however, his serum agglutinated only type 
B cells. Pretreatment of the patient’s cells with 
ficin and bromelin did not modify their reactivity 
with anti-B. Examination of a specimen two 
months later revealed similar, but weaker, findings. 
At that time the patient was much improved, 
although he continued to manifest asymptomatic 
bacteriuria. He had been hospitalized elsewhere 
in November 1969, and on that occasion he was 
found to be type A and was transfused with two 
units of type A blood without incident. 
standard ABO typing reagents and with 
Arachis hypogoea, a lectin specific for T- 
activated red blood cells.6 The results of 
these tests are given in Table 1. The direct 
antiglobulin test was negative. The pa- 
tient’s serum was tested with a variety of 
cells and found to contain anti-B and anti- 
T. His saliva contained A and H sub- 
stances. The presence of anti-T in the 
serum, and the negative result when his 
TABLE 2. Reactions of Patient’s Cells with 12 Type A Sera before and after Addition 
of Type B Secretor Saliva 
Serum Specimen 
1 2  3 4 5 6 7 8 9 10 11 12 
Before Addition of B Secretor Saliva 
Patient’s cells 3+ 2+ 3+ 4+ 4+ 0 3+ 4+ 0 0 0 3+ 
Control type B cells 4+ 4+ 4+ 4+ 3+ 3+ 3+ 4+ 2+ 4+ 4+ 4+ 
Control type 0 cells 0 0 0 0 0 0 0 0 0 0 0 0  
After Addition of B Secretor Saliva 
Patient’s cells 1 + 0  1 + 4 + 1 + 0  0 2 0  0 0 0 
Control type B cells 0 0 0 0 0 0 0 0 0 0 0 0  
Control type 0 cells 0 0 0 0 0 0 0 0 0 0 0 0  
Conditions of test: One hour at 4 C followed by centrifugation. 
BECK, ET AL. Transhion 
Sept.-Oet. 1971 
TABLE 3. Reactions at 0 C for Two Hours of Patient’s Erythrocytes with Normal Type  A B  Sera 
Serum Specimen 
1 2  3 4 . 5  6 7 8 . 9  1 0 1 1 1 2  
Patient’s cells 2+ 3+ 4+ 3+ 3+ 4+ 3+ 3+ 2+ 2+ 3+ 3+ 
A, cells 0 0 0  - c o o 0  * o o o o  
B cells 0 0 0 1 + 0  0 0 2 0 0 0 0 
0 cells 0 0 0 1 + 0  0 0 1 + 0  0 0 0 
0, T-active cells I f  2+ 0 2+ 0 2+ 2+ 2+ 3+ 0 1 +  2+ 
Oi cells (adult) 0 0 0 0 0 0 0 0 0 0 0 0  
0 cord blood cells 0 0 0 0 0 0 0 0 0 0 0 0  
The reactions given by sera 4 and 8 are considered to be due to anti-I. 
cells were tested with Aruchis hypogoea 
lectin, indicated that T-activation of the 
patient’s cells was not the cause of the 
anomalous ABO typing. 
Additional tests were performed with 
several type A sera known to be free of 
irregular antibodies (Table 2). The tests 
were repeated after the addition of type 
B secretor saliva to these sera (Table 2). 
The addition of B-substance was inhib- 
itory and supported the contention that 
this patient had acquired a B-like antigen 
on his red blood cells. This was confirmed 
by demonstrating anti-B in eluates from 
these cells following their exposure to a 
commercial anti-B typing reagent. How- 
ever, addition of type B secretor saliva to 
the eluate did not completely inhibit its 
reactivity with the patient’s cells, although 
activity with normal B cells was abolished. 
Similar results were seen when the patient’s 
cells were tested with type A sera neu- 
tralized with B-substance (Table 2 ) .  
The persistence of agglutination of the 
patient’s cells, both with normal type A 
sera and with anti-B reagents neutralized 
with B-substance, suggested reactivity of 
the cells with a high frequency agglutinin. 
Since this agglutinin also should be present 
in normal type AB serum, the patient’s 
cells were tested with a series of type AB 
sera for two hours at 0 C in an ice bath 
(Table 3). These sera had been adsorbed 
previously to remove cold auto-antibodies. 
All of these sera agglutinated the patient’s 
cells and, with the exception of two, failed 
to agglutinate normal type B cells. Re- 
moval of anti-T agglutinins by adsorption 
with T-active type 0 cells did not remove 
the agglutinin directed against the pa- 
tient’s cells. However, this agglutinin was 
inactivated by treating the serum with 2- 
mercapto-ethanol, a characteristic of IgM. 
An aliquot of the cells was frozen in 
glycerol at -20 C to permit comparison of 
their polyagglutinable properties with fu- 
ture samples. 
The acquired B antigen was detectable 
in a blood specimen examined two months 
after hospitalization, although reactions 
with anti-B sera were much weaker than 
those first seen. At that time the patient 
manifested asymptomatic bacteriuria. Ag- 
glutination of the patient’s cells at 4 C with 
type A serum was barely visible macroscop- 
ically and gave a mixed field appearance 
microscopically. Following exposure to 
anti-B typing reagent, an eluate from the 
patient’s cells yielded anti-B. The patient’s 
red blood cells reacted weakly with ten of 
12 type  AB sera although strength of reac- 
tivity was improved when the sera were 
concentrated four-fold with Carbowax. The 
concentrated sera did not react with nor- 
mal cells. 
The reactivity of these cells was com- 
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pared with that of cells collected two 
months earlier. These frozen-preserved 
cells were recovered by dialysis. The ac- 
quired-B antigen continued to be detect- 
able in the first specimen, but the cells no 
longer were agglutinated by the type AB 
sera and serum concentrates with which 
they had originally reacted. Apparently, 
storage of the cells in glycerol at -20 C 
had destroyed the receptors responsible for 
the polyagglutinability. These frozen-pre- 
served cells also had lost their ability to 
adsorb and eluate the agglutinin. Loss of 
polyagglutinability was also demonstrated 
in the more recent specimen after over- 
night storage in glycerol at -20 C. 
Discussion 
The serologic reactivity of the blood of 
this elderly man, previously found to be 
type A, permits the conclusion that his red 
blood cells temporarily had acquired a B- 
like antigen as well as polyagglutinable 
properties. 
Apparent change of a patient’s blood 
type from A to AB has been observed most 
often in association with intra-abdominal 
malignancy, infection and intestinal ob- 
struction.2, 7. 8, 19, 26 The present patient 
had a urinary tract infection. I t  is reason- 
able to assume a common cause of the poly- 
agglutinability and the change in ABO 
specificity, since both apparently were ac- 
quired during the same infection. Further- 
more, the strength of both acquired char- 
acteristics fluctuated with the severity of 
the infection. 
The mechanism by which the B-like anti- 
gen is acquired by red blood cells is un- 
clear. Springer and Ansell23 suggested that 
this may occur through passive adsorption 
of bacterial lipopolysaccharide. T o  sup 
port this contention, Springer24 reported 
that lipopolysaccharide from certain strains 
of E. coli (E. coli OS6) had terminal galac- 
tosyl groups which conferred blood type B 
specificity to human red blood cells in uitro. 
In contrast, Marsh19 favors enzymatic modi- 
fication of the red blood cells as the cause 
of the reaction. This is based on his ob- 
servation that bacterial enzymes could con- 
fer a B-like antigen to red blood cells, as 
well as producing red blood cell T-activa- 
tion. 
The type of polyagglutinability mani- 
fested by this patient’s red blood cells is a 
more intriguing problem than is the ac- 
quired B antigen. The absence of T-activa- 
tion of the red blood cells is not unique, 
lor it is well established that polyagglutina- 
tion can occur by other means. Such 
“atypical” polyagglutination has been re- 
lated to Tn-activation of the red blood 
cell, and five such cases have been re- 
Both T- and Tn-activation result from 
enzymatic activity on the red blood cell 
surface; however, it is likely that different 
enzymes are involved. Both T- and Tn- 
activated cells manifest reduced sialic acid 
1evels.S. 16. 27 This is associated with loss 
of the MN antigens in the fully T-activated 
cell, although this has not been observed 
in Tn-activation. This suggests that, al- 
though sialic acid is lost in each instance, 
different substrates are modified. 
This patient’s polyagglutinability disap 
peared following storage at -20 C. Fur- 
thermore, in contrast to T-activated eryth- 
rocytes, this patient’s cells failed to react 
with IgG Rh antisera. I t  has been demon- 
strated in this laboratory that both T- and 
Tn-activated cells retain their polyagglutin- 
ability for many months at -20 C.4 There- 
fore, this suggests that passive adsorption, 
rather than an enzymatic change, is the 
most likely cause of the patient’s reaction. 
The instability of this patient’s red 
blood cell polyagglutinability constitutes 
an important differential feature. Such 
instability of polyagglutination also was 
observed in patients reported by Garratty12 
and Stratton.25 Garratty’s patient was 
ported.5, 13. 14, 15. 20 
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analogous to ours, in that an acquired B 
antigen was present. 
Another report of unusual polyagglu- 
tination is that of Freiesleben et aZ.,*l who 
described permanent mixed field poly- 
agglutination in a blood donor, with no 
demonstrable red blood cell T-activation. 
Cazalg reported polyagglutination, in the 
absence of T-activation, in three members 
of the same family. We are also aware of a 
patient who had red blood cell polyagglu- 
tinability due to Tn-activation with an 
associated acquired A antigen.5 
The above reports indicate that at least 
four types of red blood cell polyagglutina- 
tion can be recognized, the characteristics 
of each being sufficiently distinct to permit 
the following classification: 
Type  I.  Typical T-activation 
These red blood cells manifest transient 
polyagglutination associated with bacterial 
infection.l.10.18,2~ 22 The erythrocytes are 
reactive with Arachis lectins and are de- 
ficient in Sp, antigen.3 The strength of 
reactivity of the MN antigens is diminished 
in direct proportion to the degree of T- 
activation.' These findings indicate en- 
zymatic changes in vivo. The polyagglu- 
tinability is resistant to freezing in glycerol, 
and the anti-T agglutinins, found in all 
normal adult sera, are absent. 
Type  ZZ. Atypical Polyagglutination due 
to  Tn 
Red blood cells polyagglutinable due to 
the presence of the T n  antigen are not 
agglutinated by Arachis lectins; however, 
those cells lacking the A, antigen continue 
to react with Dolichos lectins. The polyag- 
glutination appears to be a prolonged, if 
not a permanent feature of the patient, as 
a result of enzymatic activity in vivo. The 
majority of patients with this phenomenon 
have had either anemia, leukopenia or 
thrombocytopenia.s. 13-15t20 
Type 111. Polyagglutination with Acquired 
B Antigen 
This type of erythrocyte polyagglutina- 
bility, manifested by the patient in this re- 
port, appears to be associated with an ac- 
quired B antigen. Both our patient and 
the one described by Garratty12 had a 
history of bacterial infection coincident 
with the red blood cell polyagglutinability, 
and only the acquired B antigen was 
demonstrable after the red blood cells had 
been stored in glycerol at -20 C. Type 
I11 polyagglutinable cells are not agglu- 
tinated by Arachis or Dolichos lectins. The 
agglutinin for the acquired antigen appears 
to be a regular feature of normal sera and 
is distinct from anti-T and anti-Tn. The 
expression of the MN antigens is normal 
and we suspect that the Sp, antigen is un- 
affected. In  contrast to other types, T y p e  
111 polyagglutinability probably is the re- 
sult of adsorption in vivo of the antigenic 
material of bacterial origin. 
Type Z V .  Znheritab le Polyagglutination 
This red blood cell anomaly is typified 
by the Cad family described by Cazal et al.9 
The antigen is an inheritable surface re- 
ceptor reactive with most human sera. 
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